Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're based in Aberdeen and looking into Mounjaro for weight management, the short answer is this: Mounjaro is a prescription-only medicine in the UK, which means you need a clinical assessment before any treatment can begin. It cannot be purchased over the counter or through an unregulated seller. Mounjaro (tirzepatide) is licensed for adults with a BMI of 30 or above, or 27 and above where at least one weight-related condition is present, and every prescription must be issued by a qualified prescriber who has reviewed your individual health picture. Whether that assessment happens through a local GP practice or a regulated online clinic like nume, the process starts the same way: a proper consultation, not a shortcut.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide, sold in the UK as Mounjaro by Eli Lilly, works by activating two gut-hormone receptors simultaneously — GIP and GLP-1. This dual action slows gastric emptying, raises feelings of fullness and reduces appetite in a way no other licensed weight-loss medicine currently replicates. The NHS describes the mechanism clearly in its tirzepatide medicines guidance, and it is worth reading if you want to understand what the treatment actually does before you start.
Because Mounjaro affects hormonal signalling and carries a meaningful side-effect profile, UK law classifies it as a Prescription-Only Medicine under the Human Medicines Regulations 2012. That classification exists to protect you, not to create a bureaucratic hurdle. A prescriber needs to check for contraindications, assess your current medicines, confirm your weight, and review your health history. No legitimate source can dispense it without that step completed first.
Treatment begins at a 2.5mg starter pen, designed to let your system adjust gradually. The dose is then titrated upward by your prescriber, typically in four-week steps, through 5mg, 7.5mg, 10mg, 12.5mg and up to 15mg. The starting dose is about settling in, not about immediate results. If you want a fuller picture of what the evidence says about outcomes, our summary of the clinical trial programme covers the SURMOUNT research in plain English.
NHS Grampian follows the national rollout framework set out by NHS England and NICE. NICE approved tirzepatide for NHS use in December 2024 (Technology Appraisal 1026), but access is being phased in by eligibility cohort. As of summer 2026, NHS prescribing is open to adults with a BMI of 40 or above who also have four or more qualifying conditions from a defined list, including type 2 diabetes, high blood pressure, dyslipidaemia, obstructive sleep apnoea and cardiovascular disease. A second cohort, covering BMI 35–39.9 with four or more conditions, activated in June 2026.
Scotland's devolved health system applies slightly different thresholds and referral pathways, so the exact criteria your GP in Aberdeen works to may differ from NHS England guidance. The honest picture is that most people asking about Mounjaro today do not yet meet the NHS threshold, and those who do may face a wait. That is not a criticism of the NHS, it is simply the reality of a large phased rollout. For context on what GLP-1 medicines for weight loss currently mean on the NHS, NHS England's weight-management injections page sets it out honestly.
If you do not meet NHS criteria, or prefer not to wait, a regulated private clinic is the legal alternative. The important word there is regulated.
Regulated online pharmacies can issue private prescriptions for Mounjaro to patients across the UK, including those based in Aberdeen and the wider Grampian area. Geography is not the constraint. The constraint is clinical suitability, assessed by a real prescriber. Any clinic worth using will be registered with the GPhC, you can check a pharmacy's registration number directly at the GPhC pharmacy register. If a seller cannot point you there, that is a meaningful red flag.
At nume, consultations are reviewed the same working day by a GPhC-registered Independent Prescriber, a named clinician reads your answers, not software. Identity and current weight are verified through photo ID and live video. If your prescription is approved before midday on a weekday, your treatment is dispatched the same day and arrives by DPD the following working day, in plain unbranded packaging. It fits around a normal day: many patients in Aberdeen order before the school run and have their pen confirmed by the afternoon. The full consultation process is free to start, with no subscription attached.
On the question of cost, Mounjaro is not inexpensive through any legitimate private route. Eli Lilly raised UK list prices significantly from September 2025, and typical private prices now range roughly £149–£375 per month depending on dose and provider. Our Mounjaro cost page explains what those figures include and what they often leave out. What should concern you more than the price is the supply chain: fake tirzepatide pens have been manufactured and seized in the UK, and the MHRA has warned explicitly about the risks of buying weight-loss injections from unverified sources. Report any suspect seller through the MHRA Yellow Card scheme.
Private licensed eligibility broadly mirrors the SmPC: adults aged 18 or over, BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as prediabetes, hypertension, high cholesterol or obstructive sleep apnoea. Lower thresholds apply for some ethnic backgrounds under UK clinical guidance. A BMI figure alone does not guarantee approval. The prescriber weighs the full picture, including current medicines, any history of pancreatitis, thyroid conditions, and whether you are pregnant, breastfeeding or trying to conceive. Mounjaro is not recommended during pregnancy, and women using oral contraceptives should discuss additional contraceptive precautions with their prescriber, since tirzepatide can reduce pill absorption in the first weeks of treatment and after each dose increase.
If any of this raises questions specific to your health history, our frequently asked questions cover many of the common ones, and our prescribing team can be reached through the contact page. For a broader view of the treatment landscape alongside Mounjaro, the weight-loss treatments overview gives a balanced comparison. The next step, if you want to explore further, is simply checking your eligibility through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.